BCL2 and cancer: It contains a nucleolin-targeting As1411 sequenceas the backbone, which is appended with a short sequence for partialhybridization with the antisense ON 4625, which can inhibit the antiapoptoticfunction of Bcl-2 and Bcl-xL inducing apoptosis in cancer cells.